Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2018

Feb 23, 2018

29821_dirs_2018-02-23_39f79298-960a-492b-836e-b2d8c686e1b7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-02-22

Reporting Person: Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-22 Common Stock M 4055.0000 $0.0000 Acquired 178492.0000 Direct
2018-02-22 Common Stock F 1850.0000 $26.4800 Disposed 176642.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-22 Deferred Stock Units $ M 4055.0000 Disposed 2021-02-22 Common Stock (4055.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 77323.0000 Indirect

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.